Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $629.06M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TYRA | TYRA BIOSCIENCES INC | $1.77B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KGC | KINROSS GOLD CORP | $36.32B | 0.23% | 5.70% | $0.0400 | $0.07 | 4% | 0 | 2026-05-21 | 2026-06-04 |
| VKTX | VIKING THERAPEUTICS INC | $3.67B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $155.83M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.59B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BLLN | BILLIONTOONE INC | $4.27B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| LBRX | LB PHARMACEUTICALS INC | $917.02M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DNLI | DENALI THERAPEUTICS INC | $3.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NYXH | NYXOAH SA | $137.68M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $217.54M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CLYM | CLIMB BIO INC | $681.97M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.34B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VIST | VISTA ENERGY SAB DE CV | $6.92B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.48B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CLSK | CLEANSPARK INC | $3.58B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EVER | EVERQUOTE INC | $728.69M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SLDB | SOLID BIOSCIENCES INC | $695.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PCVX | VAXCYTE INC | $7.43B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $890.94M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SEPN | SEPTERNA INC | $1.08B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $410.16M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.